OSI Pharmaceuticals, Inc. · Melville, NY United States ·(NASDAQ (GS): OSIP)
Company Description
Phone: 631-962-2000
Fax: 631-752-3880
Rankings
- S&P 400
View OSI Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Fighting disease in small ways is what OSI Pharmaceuticals is all about. The company focuses on small molecule cures for diseases like cancer, allowing for treatment by pill rather than IV infusion. Its top seller Tarceva treats non-small cell lung cancer and pancreatic cancer and is in development for other indications as well. Partner Genentech co-promotes the drug in the US, and it is marketed internationally by Roche . OSI also has a pipeline of drug candidates focused on new anti-cancer compounds. UK subsidiary Prosidion manages the company's small molecule patents for diabetes and obesity treatments, bringing in about $100 million annually. Prosidion also serves as OSI's diabetes and obesity R&D center. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key OSI Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (GS): OSIP Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $379.4 |
| 2008 Employees | 514 |
OSI Pharmaceuticals, Inc. Executives
21 executives listed for OSI Pharmaceuticals, Inc.'s Melville, NY location.
| Title | Name & Bio | Contact |
| Chairman | Robert Ingram | Network |
| CEO and Director | Colin Goddard | Network |
| EVP, CFO, and Treasurer | Pierre Legault | Network |
Competition
Competitive Landscape for OSI Pharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top OSI Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!